Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
10.38
-0.10 (-0.95%)
At close: Mar 28, 2025, 4:00 PM
10.30
-0.08 (-0.76%)
Pre-market: Mar 31, 2025, 8:41 AM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $7.41 billion as of March 31, 2025. Its market cap has decreased by -13.45% in one year.
Market Cap
7.41B
Enterprise Value
2.36B
1-Year Change
-13.45%
Ranking
Category
Stock Price
$10.38
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $7.41B, an increase of 1,288.63%. That is a compound annual growth rate of 84.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 7.41B | -13.99% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |